Literature DB >> 20421444

Probiotics and intestinal colonization by vancomycin-resistant enterococci in mice and humans.

Magali Vidal1, Christiane Forestier, Nicolas Charbonnel, Sandrine Henard, Christian Rabaud, Olivier Lesens.   

Abstract

We investigated the impact of probiotics on the intestinal carriage of vancomycin-resistant enterococci (VRE). Administration of Lactobacillus rhamnosus Lcr35 but not Escherichia coli Nissle reduced, although not significantly, the density of VRE colonization in a murine model. No effect of Lcr35 was observed in a double-blind placebo randomized study, involving nine patients.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20421444      PMCID： PMC2897524          DOI： 10.1128/JCM.00473-10

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  7 in total

Review 1.  SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and enterococcus.

Authors:  Carlene A Muto; John A Jernigan; Belinda E Ostrowsky; Hervé M Richet; William R Jarvis; John M Boyce; Barry M Farr
Journal:  Infect Control Hosp Epidemiol       Date:  2003-05       Impact factor: 3.254

2.  Outbreak of colonization and infection with vancomycin-resistant Enterococcus faecium in a French university hospital.

Authors:  Olivier Lesens; L Mihaila; F Robin; O Baud; J P Romaszko; O Tourniac; J M Constantin; B Souweine; R Bonnet; A Bouvet; J Beytout; O Traore; H Laurichesse
Journal:  Infect Control Hosp Epidemiol       Date:  2006-08-24       Impact factor: 3.254

3.  Temperature gradient gel electrophoresis analysis of 16S rRNA from human fecal samples reveals stable and host-specific communities of active bacteria.

Authors:  E G Zoetendal; A D Akkermans; W M De Vos
Journal:  Appl Environ Microbiol       Date:  1998-10       Impact factor: 4.792

4.  Effect of parenteral antibiotic administration on persistence of vancomycin-resistant Enterococcus faecium in the mouse gastrointestinal tract.

Authors:  C J Donskey; J A Hanrahan; R A Hutton; L B Rice
Journal:  J Infect Dis       Date:  1999-08       Impact factor: 5.226

5.  Probiotic treatment of vancomycin-resistant enterococci: a randomised controlled trial.

Authors:  Karen J Manley; Margaret B Fraenkel; Barrie C Mayall; David A Power
Journal:  Med J Aust       Date:  2007-05-07       Impact factor: 7.738

6.  Alterations of the dominant faecal bacterial groups in patients with Crohn's disease of the colon.

Authors:  P Seksik; L Rigottier-Gois; G Gramet; M Sutren; P Pochart; P Marteau; R Jian; J Doré
Journal:  Gut       Date:  2003-02       Impact factor: 23.059

7.  Genomic and metabolic studies of the impact of probiotics on a model gut symbiont and host.

Authors:  Justin L Sonnenburg; Christina T L Chen; Jeffrey I Gordon
Journal:  PLoS Biol       Date:  2006-11       Impact factor: 8.029
  7 in total
  13 in total

Review 1.  Fighting fire with fire: is it time to use probiotics to manage pathogenic bacterial diseases?

Authors:  John Heineman; Sara Bubenik; Stephen McClave; Robert Martindale
Journal:  Curr Gastroenterol Rep       Date:  2012-08

2.  Differential Toll-like receptor recognition and induction of cytokine profile by Bifidobacterium breve and Lactobacillus strains of probiotics.

Authors:  Theo S Plantinga; Wendy W C van Maren; Jeroen van Bergenhenegouwen; Marjolijn Hameetman; Stefan Nierkens; Cor Jacobs; Dirk J de Jong; Leo A B Joosten; Belinda van't Land; Johan Garssen; Gosse J Adema; Mihai G Netea
Journal:  Clin Vaccine Immunol       Date:  2011-02-02

Review 3.  Bugs or drugs: are probiotics safe for use in the critically ill?

Authors:  Lindsay M Urben; Jennifer Wiedmar; Erica Boettcher; Rodrigo Cavallazzi; Robert G Martindale; Stephen A McClave
Journal:  Curr Gastroenterol Rep       Date:  2014

4.  Enterococci and Their Interactions with the Intestinal Microbiome.

Authors:  Krista Dubin; Eric G Pamer
Journal:  Microbiol Spectr       Date:  2014-11

5.  Escherichia coli Probiotic Strain ED1a in Pigs Has a Limited Impact on the Gut Carriage of Extended-Spectrum-β-Lactamase-Producing E. coli.

Authors:  G Mourand; F Paboeuf; M A Fleury; E Jouy; S Bougeard; E Denamur; I Kempf
Journal:  Antimicrob Agents Chemother       Date:  2016-12-27       Impact factor: 5.191

6.  Effect of Lactobacillus rhamnosus GG Administration on Vancomycin-Resistant Enterococcus Colonization in Adults with Comorbidities.

Authors:  Shira Doron; Patricia L Hibberd; Barry Goldin; Cheleste Thorpe; Laura McDermott; David R Snydman
Journal:  Antimicrob Agents Chemother       Date:  2015-05-26       Impact factor: 5.191

Review 7.  The Role of Probiotics, Prebiotics and Synbiotics in Combating Multidrug-Resistant Organisms.

Authors:  Alexander M Newman; Mehreen Arshad
Journal:  Clin Ther       Date:  2020-08-12       Impact factor: 3.393

8.  Dose-dependent immunomodulation of human dendritic cells by the probiotic Lactobacillus rhamnosus Lcr35.

Authors:  Bertrand Evrard; Sophie Coudeyras; Annie Dosgilbert; Nicolas Charbonnel; Josette Alamé; Arlette Tridon; Christiane Forestier
Journal:  PLoS One       Date:  2011-04-18       Impact factor: 3.240

Review 9.  Strategic measures for the control of surging antimicrobial resistance in Hong Kong and mainland of China.

Authors:  Vincent C C Cheng; Sally C Y Wong; Pak-Leung Ho; Kwok-Yung Yuen
Journal:  Emerg Microbes Infect       Date:  2015-02-11       Impact factor: 7.163

Review 10.  Decolonization of gastrointestinal carriage of vancomycin-resistant Enterococcus faecium: case series and review of literature.

Authors:  Vincent C C Cheng; Jonathan H K Chen; Josepha W M Tai; Sally C Y Wong; Rosana W S Poon; Ivan F N Hung; Kelvin K W To; Jasper F W Chan; Pak-Leung Ho; Chung-Mau Lo; Kwok-Yung Yuen
Journal:  BMC Infect Dis       Date:  2014-09-23       Impact factor: 3.090
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.